Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H23NO2 |
Molecular Weight | 249.3486 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C(CN)C2(O)CCCCC2
InChI
InChIKey=SUQHIQRIIBKNOR-UHFFFAOYSA-N
InChI=1S/C15H23NO2/c1-18-13-7-5-12(6-8-13)14(11-16)15(17)9-3-2-4-10-15/h5-8,14,17H,2-4,9-11,16H2,1H3
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL319 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1976813 |
900.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1976813
N,N-didesmethylvenlafaxine inhibited binding of [3H]imipramine to imipramine receptor in rat brain with IC50 value of 900 nM.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID50891440
Created by
admin on Sat Dec 16 18:22:57 GMT 2023 , Edited by admin on Sat Dec 16 18:22:57 GMT 2023
|
PRIMARY | |||
|
3235EO37UJ
Created by
admin on Sat Dec 16 18:22:57 GMT 2023 , Edited by admin on Sat Dec 16 18:22:57 GMT 2023
|
PRIMARY | |||
|
93413-77-5
Created by
admin on Sat Dec 16 18:22:57 GMT 2023 , Edited by admin on Sat Dec 16 18:22:57 GMT 2023
|
PRIMARY | |||
|
9795857
Created by
admin on Sat Dec 16 18:22:57 GMT 2023 , Edited by admin on Sat Dec 16 18:22:57 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD